Patent ID: 8324191

Claim:
A method of building bone mass, strength, microarchitecture, and density during growth, maintaining bone mass, strength, microarchitecture, and density over time, reducing bone fracture risk, and treating osteoporosis in a human, comprising administering to a human a safe and effective amount of a composition comprising an effective amount of calcium succinate, magnesium R-(+)-alpha-lipoate, and a vitamin D material selected from the group consisting of vitamin D 3 , vitamin D 2 , 25(OH)D 3 , 25(OH)D 2 , 1 α,25(OH) 2 D 3 , 1α,25(OH) 2 D 2 , and mixtures thereof wherein said safe and effective amount of said supplement is sufficient to achieve an effect selected from the group consisting of building bone mass, strength, microarchitecture, and density during growth, maintaining bone mass, strength, microarchitecture, and density over time, reducing bone fracture risk, and treating osteoporosis in a human, wherein said magnesium R-(+)-alpha-lipoate has greater than 95% purity and greater than 95% chiral purity.